There could be big money to be made based on the final results of a study to be announced at the American Society of Clinical Oncology beginning May 31. Cancer patients, doctors and pharmaceutical companies all have a lot of stake in the next wave of experimental cancer drugs, which use the human immune system to work against the disease.
NOT FOR REPRINT
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.